Submit manuscript...
International Journal of
eISSN: 2574-8084

Radiology & Radiation Therapy

Case Report Volume 5 Issue 4

Kikuchi fujimoto disease mimicking lymphoma detected on PET-CT imaging in a pediatric patient

Pelin Özcan Kara,1 Zehra P?nar Koç,2 Elvan Ça?lar Ç?tak,2 Feryal Karaman,3 Mehmet Yald?z3

1Department of Nuclear Medicine, Mersin University, Turkey
2Department of Pediatric Oncology, Mersin University, Turkey
3Department of Pathology, Mersin University, Turkey

Correspondence: Pelin Ozcan Kara, Mersin University Hospital, Department of Nuclear Medicine, 33343 Mersin, Turkey, Tel 903242410000, Fax 903242410098

Received: March 11, 2018 | Published: July 5, 2018

Citation: Kara PO, Koç ZP, Çitak EÇ, et al. Kikuchi fujimoto disease mimicking lymphoma detected on pet-ct imaging in a pediatric patient. Int J Radiol Radiat Ther. 2018;5(4):217-218. DOI: 10.15406/ijrrt.2018.05.00166

Download PDF

Abstract

Kikuchi-Fujimoto's disease (KFH), which is seen more often in young Asian women than in childhood, is a rare benign feature of PET-CT that can be confused with malignant lymphoma due to common cervical hypermetabolic lymphadenopathy and high SUV values. In this interesting case report, PET-CT imaging findings of a rare Kikuchi-Fujimoto disease mimicking lymphoma in a pediatric patient is presented.

Introduction

Kikuchi-Fujimoto's disease is a rare cause of cervical lymphadenopathy, also called subacute or histiocytic necrotizing lymphadenitis. Kikuchi-Fujimoto disease (KFD) is a benign and self-limited disorder. This disorder is initially described as a lymphadenitis with a focal proliferation of reticular cells. This disorder must be included in the differential diagnosis of 'lymph node enlargement' since its course and treatment differ dramatically from those of lymphoma, tuberculosis, and SLE. In this case report, FDG PET-CT imaging findings of a rare Kikuchi-Fujimoto disease mimicking lymphoma in a pediatric patient is presented.

Case report

A 17-year-old male patient with a pre-diagnosed lymphoma who had hepatosplenomegaly on an abdominal US examination and lymphadenopathies thought to be compatible with malignancy with heterogeneous enhancement at the level of the right neck of the neck in the US and CT examinations were undergone PET-CT imaging. PET-CT images from the calvarium to the soles of the foot revealed conglomerated lymphadenopathies (SUVmax: 4.9-11.1) on the right dominant bilateral cervical chain extending to the right supra-infraclavicular area. In addition, bilateral paraaortic, paraceliac, aortocaval and peripancreatic lymphadenopathies with a maximal size of 1 cm (SUVmax: 8.2) and diffuse FDG activity (SUVmax: 2.7/2.0) relatively increased compared to liver parenchyma in the spleen and minimal diffuse FDG activity in the bone marrow were detected. The left femur proximal posterolateral diaphyseal area showed a subcutaneous nodular probable inflammatory nodal low level of metabolic activity and possible pathological lymphadenopathy at the level of the right knee (SUVmax: 6.7) (Figure 1). A biopsy was suggested to the patient. Right cervical excisional lymph node biopsy was performed, lymphoma was excluded and the patient was diagnosed with Kikuchi Fujimoto Disease. Appropriate treatment was started and a few months later PET-CT was negative for all regions.

Figure1 Digital and plantar orthotics with medical reports.

Discussion

Kikuchi-Fujimoto disease (KFD) is a benign and self-limited disorder, characterized by regional cervical lymphadenopathy. Initially described in Japan, KFD was first reported in 1972 almost simultaneously by Kikuchi1) and by Fujimoto et al.,2 as a lymphadenitis with a focal proliferation of reticular cells accompanied by numerous histiocytes and extensive nuclear debris.3 This disorder must be included in the differential diagnosis of 'lymph node enlargement' since its course and treatment differ dramatically from those of lymphoma, tuberculosis, and SLE. The histological differential diagnosis of KFD mainly includes reactive lesions as lymphadenitis associated with SLE or herpes simplex, non-Hodgkin's lymphoma, plasmacytoid T-cell leukemia, Kawasaki's disease, myeloid tumor and even metastasic adenocarcinoma.4 Kikuchi-Fujimoto's disease (KFH), which is seen more often in young Asian women than in childhood, is a rare benign feature of PET-CT that can be confused with malignant lymphoma due to common cervical hypermetabolic lymphadenopathy and high SUV values. Lymphoma is the third most common cancer in children. In a study by 5 twenty-two patients with cervical lymphadenopathy (8 with KFD and 14 with NHL) underwent CT and FDG PET/CT scans to examine the cervical lymphadenopathy. As for SUV, a significant difference was observed only between indolent and aggressive (6.4±1.5 and 17.3±9.3, P<0.05) NHL; however, KFD showed a significantly greater corSUV (23.8±10.6) as compared with indolent NHL (9.2±5.1, P<0.05), which did not show a significant difference from aggressive NHL (21.4±10.2). FDG PET/CT detected thoracoabdominal lesions in 2 patients (25%) with KFD. KFD shows high FDG uptake for size, which may reflect the pathologic characteristics, including necrotizing lymphocytes and numerous histiocytes (macrophages) surrounding small necrotic foci. The authors concluded that FDG PET/CT will be useful for detecting noncervical lesions of KFD and distinguishing KFD from NHLs using both SUV and corSUV. In another study by Ji Eun Kim,6 the 18F-FDG PET/CT maximum standardized uptake values (SUVmax) ranged from 8.3 to 22.5 (mean, 12.0) in KFDs, and from 5.8 to 34.3 (mean, 15.9) in MLs. There were no significant differences in SUVmax between KFDs and malignant lymphoma. In this study, patients with malignant lymphoma tended to present with extranodal involvement or huge conglomerated lymphadenopathies, in comparison with KFD patients who had generalized lymphadenopathy without extranodal involvement. Although, a number of differences have been reported in the literature, such as the absence of extranodal involvement sites in KFH and the absence of hepatosplenomegaly, relatively diffuse increased FDG uptake in the spleen and bone marrow has been noted, in this case and it is not possible to make a differential diagnosis with any of these parameters.

Acknowledgements

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of interest

The author declares that there is no conflict of interest.

References

Creative Commons Attribution License

©2018 Kara, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.